UNSPSC 51172836: Phosphoric acid/sodium fluoride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR100. This VA Drug Class (OR100) classifies this compound as belonging to the group CARIOSTATICS, TOPICAL.

UNSPSC 51172836 Phosphoric acid/sodium fluoride, a Commodity code, encompasses pharmaceuticals and over-the-counter products that state and local governments procure through cooperative purchasing agreements and direct supply arrangements. The recent solicitation activity under this code reflects state and local demand for generic pharmaceuticals and OTC medications distributed through authorized wholesale channels to public health facilities, correctional institutions, schools, and other government-operated healthcare settings. State and local issuing bodies procure these products primarily through multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions to negotiate volume pricing and standardized supply agreements.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities, including Oregon. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and meet cGMP certification and Drug Supply Chain Security Act (DSCSA) compliance. Evaluation criteria emphasize price competitiveness (75 percent), with additional weightings for fixed pricing, administrative fee compliance, EDI capability, and pricing format options including flat price, net price formats (NF30, NF60, NF90), and WAC-minus structures. The contract term is two years for new responders with optional extensions at MMCAP's discretion, with awarded vendors effective July 1, 2026.